cabozantinib,avelumab
pfizer,exelixis
['javelin,bladder,100', 'atlantis', 'bladder', 'cabozantinib', 'avelumab', 'muc ,(-much)']
lba #asco22 - atlantis: phase ii trial of maintenance cabozantinib vs placebo following response to platinum-based chemo for muc no difference in mpfs no difference in mos maintenance therapy should be avelumab (presently) based on javelin bladder 100 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday